Breast Cancer Trial, Recruiting NCT07576270 Sponsor: Riphah International University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07576270
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Radiation therapy and chemotherapy must have been completed at least three months before joining the trial
  • At least six months must have passed since a mastectomy (surgical removal of one breast) for breast cancer, with either no lymphedema (arm swelling) or only early-stage (stage 1) lymphedema
  • The mastectomy must have been a complete removal of one breast (not both)
  • The person must have pain along with one or more of the following: a feeling of heaviness, numbness, pressure, stiffness, changes in how the arm or shoulder works, or limited movement in the shoulder on the side of the surgery

Who may not be able to join:

  • People who have a shoulder condition that doctors have recommended needs surgery
  • People who have a musculoskeletal injury (affecting muscles, bones, or joints) in nearby areas such as the shoulder or neck
  • People who had surgery on both breasts as part of their breast cancer treatment
  • People who had lymph nodes removed from both sides of the body
  • People who have open wounds on either arm
  • People who have circulatory (blood flow) problems
  • People who have previously had shoulder surgery for reasons unrelated to breast cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: hina gul, PhD*, Riphah International University

Phone: 03324390125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Spirometer; Circumferential limb measurements; Numerical pain rating scale (NPRS); Chest Mobility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov